Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Study reveals heart failure insights at single-cell level

Study reveals heart failure insights at single-cell level

Universal approach could potentially expand CAR T cell therapy to all blood cancers

Universal approach could potentially expand CAR T cell therapy to all blood cancers

KAUST researchers refute challenges to targeted cancer therapy

KAUST researchers refute challenges to targeted cancer therapy

NCCN publishes new resource on options, benefits of care approaches for pediatric Hodgkin lymphoma

NCCN publishes new resource on options, benefits of care approaches for pediatric Hodgkin lymphoma

New method could make single-cell RNA sequencing more accessible to patients

New method could make single-cell RNA sequencing more accessible to patients

Associations between cardiorespiratory fitness in young men and the incidence of site-specific cancer

Associations between cardiorespiratory fitness in young men and the incidence of site-specific cancer

Associations between alcohol intake, cancer risk, and modifying factors in women: smoking, BMI, and MHT interactions

Associations between alcohol intake, cancer risk, and modifying factors in women: smoking, BMI, and MHT interactions

A new Medicare proposal would cover training for family caregivers

A new Medicare proposal would cover training for family caregivers

Study finds how low levels of the TET2 gene fuel rapid growth of acute myeloid leukemia

Study finds how low levels of the TET2 gene fuel rapid growth of acute myeloid leukemia

New gene therapy shows promise for treating fusion-driven cancers

New gene therapy shows promise for treating fusion-driven cancers

Diverse gut microbiome may help children survive stem cell transplant

Diverse gut microbiome may help children survive stem cell transplant

Automated cell analysis with Haemorasis can help diagnose blood disorders

Automated cell analysis with Haemorasis can help diagnose blood disorders

The impact of epigenetic features on breast cancer treatment and outcomes

The impact of epigenetic features on breast cancer treatment and outcomes

Myelodysplastic syndromes are commonly misdiagnosed, study finds

Myelodysplastic syndromes are commonly misdiagnosed, study finds

Miniature heart model holds the key to saving lives and enhancing patient outcomes

Miniature heart model holds the key to saving lives and enhancing patient outcomes

CAR-T immune therapies could be effective against solid tumors

CAR-T immune therapies could be effective against solid tumors

NYU Langone Health included on the 2023-24 Honor Roll of top 20 hospitals

NYU Langone Health included on the 2023-24 Honor Roll of top 20 hospitals

UCSF Medical Center named to Honor Roll of nation's top hospitals

UCSF Medical Center named to Honor Roll of nation's top hospitals

IN8bio opens new cancer research lab in Birmingham's Pepper Place

IN8bio opens new cancer research lab in Birmingham's Pepper Place

Tails on engineered T cells could help fight cancer

Tails on engineered T cells could help fight cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.